Compagnie Lombard Odier SCmA Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$46.3M |
| 2 |
Blackrock
BLK
|
+$25.5M |
| 3 |
Sea Limited
SE
|
+$21.7M |
| 4 |
ServiceNow
NOW
|
+$21.2M |
| 5 |
Estee Lauder
EL
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intellia Therapeutics
NTLA
|
+$22M |
| 2 |
Tandem Diabetes Care
TNDM
|
+$20.4M |
| 3 |
APLS
Apellis Pharmaceuticals
APLS
|
+$19.4M |
| 4 |
Allogene Therapeutics
ALLO
|
+$18.9M |
| 5 |
10x Genomics
TXG
|
+$17.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Communication Services | 18.56% |
| 3 | Financials | 15.44% |
| 4 | Consumer Discretionary | 14.23% |
| 5 | Healthcare | 14.15% |
Similar funds
Compagnie Lombard Odier SCmA's Q2 2021 Portfolio in Review
As of Q2 2021, Compagnie Lombard Odier SCmA held 720 positions worth $4.55B, up 0.27% from $4.54B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Compagnie Lombard Odier SCmA withdrew a net $345M in Q2 2021, closing 92 positions and reducing 146 holdings. Its most notable exit was Allogene Therapeutics, an estimated $18.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Compagnie Lombard Odier SCmA opened a new position in Bilibili worth $9.73M.
- Compagnie Lombard Odier SCmA's largest Q2 2021 buy was Bilibili: 79,851 shares worth $9.73M.
- Compagnie Lombard Odier SCmA added most to Salesforce in Q2 2021, an estimated $46.3M increase.
- Compagnie Lombard Odier SCmA's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $22M.
- Compagnie Lombard Odier SCmA fully exited Allogene Therapeutics in Q2 2021, selling an estimated $18.9M.
- Compagnie Lombard Odier SCmA's ten largest holdings make up 41% of its $4.55B portfolio in Q2 2021.
- Compagnie Lombard Odier SCmA opened 73 new positions and closed 92 in Q2 2021.
- Compagnie Lombard Odier SCmA's portfolio value rose 0.27% quarter-over-quarter to $4.55B.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2021, filed 15 Jul 2021.